Monday, September 6, 2021 Daily Archives

PE firm 3i to create injectable CDMO ten23 health

by

3i invests in ten23 health, a CDMO focused on developing and commercializing injectable biopharmaceuticals. Private equity and venture capital firm 3i Group has partnered with CEO Hanns-Christian Mahler to form contract development manufacturing organization (CDMO) ten23 health headquarted in Basel, Switzerland. The CDMO will offer drug product development and manufacturing, testing services for sterile pharmaceutical products and formulation development. “ten23 is uniquely positioned to provide holistic design and development services with its differentiated pharmaceutical and application knowhow. ten23 health’s offering…

September 6, 2021

Going for gold: Clene ups nanocatalysis capacity to support ALS lead

by

Clene Nanomedicine has quadrupled production capacity to support candidate CNM-Au8, a gold nanocrystal suspension it says could be a gamechanger in the neurodegenerative disease space. The Utah-based biotech has entered into both a 10 year lease for a manufacturing space located in Elkton, Maryland and a seven year lease to further expand its existing manufacturing capacity nearby. The expanded capabilities will serve to support lead candidate CNM-Au8, currently in Phase II studies for amyotrophic lateral sclerosis (ALS). “In our existing…

September 6, 2021